Bangladesh
· Delayed Price · Currency is BDT Navana Pharmaceuticals Statistics
Total Valuation
DSE:NAVANAPHAR has a market cap or net worth of BDT 5.30 billion. The enterprise value is 9.31 billion.
| Market Cap | 5.30B |
| Enterprise Value | 9.31B |
Important Dates
The next estimated earnings date is Thursday, January 22, 2026.
| Earnings Date | Jan 22, 2026 |
| Ex-Dividend Date | Nov 20, 2025 |
Share Statistics
DSE:NAVANAPHAR has 107.42 million shares outstanding. The number of shares has increased by 0.56% in one year.
| Current Share Class | 107.42M |
| Shares Outstanding | 107.42M |
| Shares Change (YoY) | +0.56% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 23.53% |
| Owned by Institutions (%) | n/a |
| Float | 64.71M |
Valuation Ratios
The trailing PE ratio is 9.89.
| PE Ratio | 9.89 |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | 2.78 |
| P/OCF Ratio | 2.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.19, with an EV/FCF ratio of 4.88.
| EV / Earnings | 17.32 |
| EV / Sales | 0.98 |
| EV / EBITDA | 5.19 |
| EV / EBIT | 6.35 |
| EV / FCF | 4.88 |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.84.
| Current Ratio | 0.90 |
| Quick Ratio | 0.27 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | 2.36 |
| Debt / FCF | 2.22 |
| Interest Coverage | 2.20 |
Financial Efficiency
Return on equity (ROE) is 11.06% and return on invested capital (ROIC) is 9.38%.
| Return on Equity (ROE) | 11.06% |
| Return on Assets (ROA) | 7.99% |
| Return on Invested Capital (ROIC) | 9.38% |
| Return on Capital Employed (ROCE) | 25.98% |
| Revenue Per Employee | 1.98M |
| Profits Per Employee | 112,078 |
| Employee Count | 4,798 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 2.36 |
Taxes
In the past 12 months, DSE:NAVANAPHAR has paid 238.74 million in taxes.
| Income Tax | 238.74M |
| Effective Tax Rate | 30.75% |
Stock Price Statistics
The stock price has decreased by -7.85% in the last 52 weeks. The beta is -0.20, so DSE:NAVANAPHAR's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -7.85% |
| 50-Day Moving Average | 52.69 |
| 200-Day Moving Average | 52.98 |
| Relative Strength Index (RSI) | 41.97 |
| Average Volume (20 Days) | 331,215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:NAVANAPHAR had revenue of BDT 9.52 billion and earned 537.75 million in profits. Earnings per share was 4.99.
| Revenue | 9.52B |
| Gross Profit | 4.12B |
| Operating Income | 1.47B |
| Pretax Income | 776.49M |
| Net Income | 537.75M |
| EBITDA | 1.74B |
| EBIT | 1.47B |
| Earnings Per Share (EPS) | 4.99 |
Balance Sheet
The company has 163.42 million in cash and 4.24 billion in debt, giving a net cash position of -4.02 billion or -37.39 per share.
| Cash & Cash Equivalents | 163.42M |
| Total Debt | 4.24B |
| Net Cash | -4.02B |
| Net Cash Per Share | -37.39 |
| Equity (Book Value) | 5.05B |
| Book Value Per Share | 47.03 |
| Working Capital | -582.29M |
Cash Flow
In the last 12 months, operating cash flow was 2.08 billion and capital expenditures -170.92 million, giving a free cash flow of 1.91 billion.
| Operating Cash Flow | 2.08B |
| Capital Expenditures | -170.92M |
| Free Cash Flow | 1.91B |
| FCF Per Share | 17.75 |
Margins
Gross margin is 43.23%, with operating and profit margins of 15.40% and 5.65%.
| Gross Margin | 43.23% |
| Operating Margin | 15.40% |
| Pretax Margin | 8.16% |
| Profit Margin | 5.65% |
| EBITDA Margin | 18.32% |
| EBIT Margin | 15.40% |
| FCF Margin | 20.03% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 2.84%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 2.84% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 7.73% |
| Buyback Yield | -0.56% |
| Shareholder Yield | 2.28% |
| Earnings Yield | 10.15% |
| FCF Yield | 36.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DSE:NAVANAPHAR has an Altman Z-Score of 1.87 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.87 |
| Piotroski F-Score | 6 |